Attention to principles of exercise training: a review of exercise studies for survivors of cancers other than breast.
Kerri M Winters-Stone, Sarah E Neil, Kristin L Campbell
https://pubmed.ncbi.nlm.nih.gov/23293010/Actively Recruiting
Led by Medical University of Graz · Updated on 2026-06-09
50
Participants Needed
1
Research Sites
30 weeks
Total Duration
Researchers are studying the effects of a 12-week exercise training program on patients with non-small cell and small-cell lung cancer. Lung cancer is a leading cause of cancer deaths worldwide, and while exercise is known to lower the risk of some cancers and improve immune response, its role as part of routine lung cancer treatment remains unclear. This study aims to compare moderate-intensity continuous exercise MICE, high-intensity interval exercise HIIT, and standard exercise recommendations to understand their impact on immune system markers and physical health in lung cancer patients. Participants will be randomly assigned to one of three groups one group will perform supervised moderate-intensity continuous exercise twice a week plus home walking five times a week another group will do supervised high-intensity interval exercise twice weekly plus the same home walking and a control group will receive general exercise advice without supervised sessions or home walking requirements. The exercise programs follow a defined frequency, intensity, type, and time F.I.T.T. principle, with medical supervision during sessions. Throughout the study, participants will have blood samples taken to analyze immune cell characteristics and cytokine profiles using advanced techniques like FACS analysis, mitochondrial function testing, and lipid profiling. The study will also assess aerobic capacity, quality of life using validated questionnaires, and body composition before and after the 12-week intervention. These measurements will help evaluate how exercise might influence the immune response and overall well-being during lung cancer treatment.
CONDITIONS
EXERCISE AND THE IMMUNE RESPONSE IN LUNG CANCER
L
Lukas Spielbüchler, MEd, BEd
E
Emine Betül Deniz, MSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Medical University of Graz
Lead Sponsor
Austrian Science Fund (FWF)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 12 weeks
Participants undergo a 12-week exercise program according to their assigned group: supervised moderate-intensity continuous exercise, supervised high-intensity interval exercise, or receive general exercise recommendations without supervised sessions. They also perform home-based walking exercises as advised.
Twice weekly supervised sessions plus daily home walking exercises
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Kerri M Winters-Stone, Sarah E Neil, Kristin L Campbell
https://pubmed.ncbi.nlm.nih.gov/23293010/Leandro Fórnias Machado de Rezende, Thiago Hérick de Sá, Georgios Markozannes...
https://pubmed.ncbi.nlm.nih.gov/29146752/Kristin L Campbell, Kerri M Winters-Stone, Joachim Wiskemann...
https://pubmed.ncbi.nlm.nih.gov/31626055/Zoltan Ungvari, Mónika Fekete, Péter Varga...
https://pubmed.ncbi.nlm.nih.gov/40220151/Kathleen A Ashcraft, Ralph M Peace, Allison S Betof...
https://pubmed.ncbi.nlm.nih.gov/27381680/Asunción Martín-Ruiz, Carmen Fiuza-Luces, Cecilia Rincón-Castanedo...
https://pubmed.ncbi.nlm.nih.gov/32139351/Medical University of Graz
Lead Sponsor
Austrian Science Fund (FWF)
Collaborating Sponsor